Letter to editor regarding the systematic review and meta-analysis by Coleman et al. on the effectiveness of MF59-adjuvanted seasonal influenza vaccine in older adults.
作者信息
Yin J Kevin, Samson Sandrine I, Nealon Joshua
机构信息
Global Medical, Sanofi Pasteur, Singapore.
The University of Sydney, Camperdown, NSW, Australia.
出版信息
Influenza Other Respir Viruses. 2021 Nov;15(6):826-827. doi: 10.1111/irv.12891. Epub 2021 Aug 2.
Abstract
摘要
相似文献
1
Letter to editor regarding the systematic review and meta-analysis by Coleman et al. on the effectiveness of MF59-adjuvanted seasonal influenza vaccine in older adults.致编辑的信：关于科尔曼等人对MF59佐剂季节性流感疫苗在老年人中的有效性进行的系统评价和荟萃分析
Influenza Other Respir Viruses. 2021 Nov;15(6):826-827. doi: 10.1111/irv.12891. Epub 2021 Aug 2.
2
Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis.MF59 佐剂三价或四价季节性流感疫苗在 65 岁及以上成年人中的有效性：系统评价和荟萃分析。
Influenza Other Respir Viruses. 2021 Nov;15(6):813-823. doi: 10.1111/irv.12871. Epub 2021 Jun 3.
3
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.MF59佐剂季节性流感疫苗在老年人中的有效性：一项系统评价和荟萃分析。
Vaccine. 2017 Jan 23;35(4):513-520. doi: 10.1016/j.vaccine.2016.12.011. Epub 2016 Dec 23.
4
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.一项针对老年人的剂量范围研究，以比较皮内和肌肉注射MF59®佐剂和非佐剂季节性流感疫苗后的安全性和免疫原性特征。
Hum Vaccin Immunother. 2014;10(6):1701-10. doi: 10.4161/hv.28618. Epub 2014 Apr 14.
5
An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.AS03 和 MF59 佐剂在大流行性流感 A(H1N1)pdm09 疫苗中的间接比较荟萃分析。
Vaccine. 2019 Jul 18;37(31):4246-4255. doi: 10.1016/j.vaccine.2019.06.039. Epub 2019 Jun 26.
6
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy.在意大利北部进行的 MF59 佐剂流感疫苗与非佐剂流感疫苗的比较研究结果：评估老年人接种 MF59 佐剂流感疫苗的安全性。
Am J Epidemiol. 2013 Oct 1;178(7):1139-45. doi: 10.1093/aje/kwt078. Epub 2013 Jul 17.
7
Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience.含佐剂的三价季节性流感疫苗在 65 岁及以上老年人中的免疫原性：累积临床经验的荟萃分析。
Int J Infect Dis. 2019 Aug;85S:S1-S9. doi: 10.1016/j.ijid.2019.03.026. Epub 2019 Mar 26.
8
Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly.老年人中传统亚单位疫苗、MF59佐剂疫苗和皮内注射流感疫苗的免疫原性和安全性比较。
Clin Vaccine Immunol. 2014 Jul;21(7):989-96. doi: 10.1128/CVI.00615-13. Epub 2014 May 14.
9
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.使用MF59佐剂四价流感疫苗在非匹配季节预防老年人流感：一项随机、对照、多中心3期疗效研究。
Lancet Infect Dis. 2021 Jul;21(7):1027-1037. doi: 10.1016/S1473-3099(20)30694-0. Epub 2021 Feb 9.
10
[Efficacy, effectiveness and safety of the adjuvanted influenza vaccine in the population aged 65 or over].[佐剂流感疫苗在65岁及以上人群中的有效性、效果及安全性]
Rev Esp Quimioter. 2023 Aug;36(4):334-345. doi: 10.37201/req/145.2022. Epub 2023 Apr 20.
引用本文的文献
1
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain.对西班牙老年人群流感疫苗经济评估中不确定性的批判性评估。
BMC Infect Dis. 2025 Feb 1;25(1):152. doi: 10.1186/s12879-025-10442-3.
2
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population.高剂量四价流感疫苗与佐剂四价流感疫苗在意大利老年人群中的成本效益比较。
Front Public Health. 2023 Nov 13;11:1200116. doi: 10.3389/fpubh.2023.1200116. eCollection 2023.
3
Reply to Letter to the Editor by Yin et al.
Influenza Other Respir Viruses. 2021 Nov;15(6):828-829. doi: 10.1111/irv.12895. Epub 2021 Aug 10.
本文引用的文献
1
Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis.MF59 佐剂三价或四价季节性流感疫苗在 65 岁及以上成年人中的有效性：系统评价和荟萃分析。
Influenza Other Respir Viruses. 2021 Nov;15(6):813-823. doi: 10.1111/irv.12871. Epub 2021 Jun 3.
2
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.使用MF59佐剂四价流感疫苗在非匹配季节预防老年人流感：一项随机、对照、多中心3期疗效研究。
Lancet Infect Dis. 2021 Jul;21(7):1027-1037. doi: 10.1016/S1473-3099(20)30694-0. Epub 2021 Feb 9.
3
Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review.在评估流感疫苗效力的观察性研究中，适应症混杂和健康疫苗接种者偏倚的频率及影响：一项系统综述
BMC Infect Dis. 2015 Oct 17;15:429. doi: 10.1186/s12879-015-1154-y.
4
Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study.在老年人群中，佐剂流感疫苗比三价灭活疫苗更有效吗？一项病例对照研究的结果。
Vaccine. 2014 Sep 15;32(41):5290-4. doi: 10.1016/j.vaccine.2014.07.077. Epub 2014 Aug 1.
5
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.佐剂和未佐剂三价灭活流感疫苗（TIV）在老年人中的比较效果。
Vaccine. 2013 Dec 9;31(51):6122-8. doi: 10.1016/j.vaccine.2013.07.059. Epub 2013 Aug 6.
6
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.含佐剂季节性流感疫苗（Fluad ® 和 In-flexal V ® ）在预防老年人因流感和肺炎住院方面的有效性：一项匹配病例对照研究。
Hum Vaccin Immunother. 2013 Jan;9(1):144-52. doi: 10.4161/hv.22231. Epub 2012 Nov 10.
7
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy.意大利北部老年人中含佐剂流感疫苗的有效性。
Am J Epidemiol. 2012 Sep 15;176(6):527-33. doi: 10.1093/aje/kws313. Epub 2012 Aug 31.
8
Measuring inconsistency in meta-analyses.评估荟萃分析中的异质性
BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.
Zotero 插件